Baker Bros. Advisors LP Portfolio Holdings

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024

Baker Bros. Advisors LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $9.34 Billion distributed in 93 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bei Gene, Ltd. with a value of $2.37B, Incyte Corp with a value of $2.03B, Acadia Pharmaceuticals Inc with a value of $660M, Summit Therapeutics Inc. with a value of $535M, and Madrigal Pharmaceuticals, Inc. with a value of $419M.

Examining the 13F form we can see an increase of $1.81B in the current position value, from $7.52B to 9.34B.

Baker Bros. Advisors LP is based out at New York, NY

Below you can find more details about Baker Bros. Advisors LP portfolio as well as his latest detailed transactions.

Portfolio value $9.34 Billion
Healthcare: $9.33 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$541M
$8.21 Million 0.09% of portfolio
1,160,117
Q2 2023 Added 308.49%
$97.2M
$8.05 Million 0.09% of portfolio
4,004,756
Q4 2023 Added 59.89%
$1.56B
$7.43 Million 0.08% of portfolio
190,476
Q3 2023 New
$5.33B
$5.58 Million 0.06% of portfolio
48,885
Q4 2022 New
$2.98B
$5.31 Million 0.06% of portfolio
103,927
Q2 2024 New
$260M
$5.78 Million 0.06% of portfolio
750,000
Q3 2021 New
$163M
$4.33 Million 0.05% of portfolio
927,264
Q2 2024 New
$68.5M
$4.8 Million 0.05% of portfolio
1,944,945
Q3 2024 Added 61.14%
$276M
$3.98 Million 0.04% of portfolio
1,028,466
Q4 2022 New
$432M
$3.51 Million 0.04% of portfolio
151,329
Q2 2024 New
$151M
$2.87 Million 0.03% of portfolio
1,557,630
Q4 2022 New
$1.17B
$2.82 Million 0.03% of portfolio
344,063
Q3 2024 New
$201M
$2.05 Million 0.02% of portfolio
1,086,115
Q2 2023 Reduced 42.42%
$71.2M
$479,000 0.01% of portfolio
322,024
Q3 2022 New
$1.39B
$575,000 0.01% of portfolio
75,778
Q2 2024 Reduced 99.25%
$62.6M
$1.31 Million 0.01% of portfolio
628,939
Q2 2024 Reduced 62.57%
$61.2M
$982,000 0.01% of portfolio
536,832
Q2 2024 Added 168.86%
$148B
$1.01 Million 0.01% of portfolio
35,000
Q4 2023 New
Aligos Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q3 2024 New
Structure Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q3 2024 New
-
$0 0.0% of portfolio
-
Q1 2024 New
Alumis Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New
$0
$8,000 0.0% of portfolio
833,333
Q3 2021 New
$632M
$249,000 0.0% of portfolio
10,607
Q4 2023 New
Kala Bio, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 Added 234.32%
V Tv Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 New
Bicara Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q3 2024 New
Skye Bioscience, Inc.
-
$0 0.0% of portfolio
-
Q3 2024 Added 186.93%
Leap Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2023 New
Kiniksa Pharmaceuticals International, PLC
-
$0 0.0% of portfolio
-
Q2 2024 New
Neumora Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 Added 63.22%
Neurogene Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Added 0.55%
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.12%
Opthea Limited
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 0.19%
Praxis Precision Medicines, Inc.
-
$0 0.0% of portfolio
-
Q3 2024 Added 145.65%
Hookipa Pharma Inc.
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 90.0%
$229M
$419,000 0.0% of portfolio
45,027
Q4 2021 New
Enliven Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 New
Dbv Technologies S.A.
-
$0 0.0% of portfolio
-
Q2 2024 New
Sagimet Biosciences Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 5.12%
Contineum Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New
Insmed Incorporated
-
$0 0.0% of portfolio
-
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 93
  • Current Value $9.34 Billion
  • Prior Value $7.52 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 6 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email